Also known as: Romazicon / Anexate (brand)
Flumazenil is a competitive benzodiazepine receptor antagonist used for the reversal of benzodiazepine-induced sedation and to manage benzodiazepine overdose. It acts at GABA-A receptors, rapidly reversing CNS depression caused by benzodiazepine agents.
Mediocon Inc manufactures Flumazenil IP/BP/USP with high purity suitable for parenteral and injectable pharmaceutical formulations across critical care settings. Every batch undergoes rigorous quality testing ensuring full compliance with pharmacopoeial standards.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% & NMT 102.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 10 ppm |
| Residual Solvents | Complies ICH Q3C |
| Microbial Limits | Complies |
| Identification | HPLC & IR Compliant |
| pH (1% solution) | 4.5 – 6.5 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Flumazenil (CAS 78755-81-4) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Flumazenil is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance